| pubmed-article:11303415 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11303415 | lifeskim:mentions | umls-concept:C0040261 | lld:lifeskim |
| pubmed-article:11303415 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11303415 | lifeskim:mentions | umls-concept:C1511726 | lld:lifeskim |
| pubmed-article:11303415 | lifeskim:mentions | umls-concept:C1518527 | lld:lifeskim |
| pubmed-article:11303415 | lifeskim:mentions | umls-concept:C0220812 | lld:lifeskim |
| pubmed-article:11303415 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11303415 | pubmed:dateCreated | 2001-4-16 | lld:pubmed |
| pubmed-article:11303415 | pubmed:abstractText | To estimate component and total costs of treatment and to examine differences in cost and cost effectiveness between oral antifungal medication and local therapy for patients with toenail onychomycosis. | lld:pubmed |
| pubmed-article:11303415 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11303415 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11303415 | pubmed:citationSubset | T | lld:pubmed |
| pubmed-article:11303415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11303415 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11303415 | pubmed:issn | 1170-7690 | lld:pubmed |
| pubmed-article:11303415 | pubmed:author | pubmed-author:ScheidPP | lld:pubmed |
| pubmed-article:11303415 | pubmed:author | pubmed-author:HenkeCC | lld:pubmed |
| pubmed-article:11303415 | pubmed:author | pubmed-author:DoyleJJ | lld:pubmed |
| pubmed-article:11303415 | pubmed:author | pubmed-author:StierD MDM | lld:pubmed |
| pubmed-article:11303415 | pubmed:author | pubmed-author:SchonfeldW... | lld:pubmed |
| pubmed-article:11303415 | pubmed:author | pubmed-author:BroeringJJ | lld:pubmed |
| pubmed-article:11303415 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11303415 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:11303415 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11303415 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11303415 | pubmed:pagination | 267-79 | lld:pubmed |
| pubmed-article:11303415 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11303415 | pubmed:meshHeading | pubmed-meshheading:11303415... | lld:pubmed |
| pubmed-article:11303415 | pubmed:meshHeading | pubmed-meshheading:11303415... | lld:pubmed |
| pubmed-article:11303415 | pubmed:meshHeading | pubmed-meshheading:11303415... | lld:pubmed |
| pubmed-article:11303415 | pubmed:meshHeading | pubmed-meshheading:11303415... | lld:pubmed |
| pubmed-article:11303415 | pubmed:meshHeading | pubmed-meshheading:11303415... | lld:pubmed |
| pubmed-article:11303415 | pubmed:meshHeading | pubmed-meshheading:11303415... | lld:pubmed |
| pubmed-article:11303415 | pubmed:meshHeading | pubmed-meshheading:11303415... | lld:pubmed |
| pubmed-article:11303415 | pubmed:meshHeading | pubmed-meshheading:11303415... | lld:pubmed |
| pubmed-article:11303415 | pubmed:meshHeading | pubmed-meshheading:11303415... | lld:pubmed |
| pubmed-article:11303415 | pubmed:meshHeading | pubmed-meshheading:11303415... | lld:pubmed |
| pubmed-article:11303415 | pubmed:meshHeading | pubmed-meshheading:11303415... | lld:pubmed |
| pubmed-article:11303415 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11303415 | pubmed:articleTitle | Cost of treatment for onychomycosis. Data from a 9-month observational study. | lld:pubmed |
| pubmed-article:11303415 | pubmed:affiliation | Eureka Research, San Francisco, California, USA. | lld:pubmed |
| pubmed-article:11303415 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11303415 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
